ScreenerHero
BMXBioMaxima S.A.
GPW · PL · Healthcare · Diagnostics & Research · biomaxima.com
10.08PLN-1.18%Mkt Cap: 10.70M $P/E: —

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and medi…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap10.70M $
Enterprise Value14.81M $
Revenue (TTM)15.13M $
Gross Profit6.75M $
Net Income (TTM)26.59K $
Revenue/Share3.608 USD
Last Price10.08 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees143
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLBIOMX00015
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA15.91
EV/Revenue0.98
P/S0.72
P/B0.89
EPS (TTM)-0.03
EPS (Forward)—
52W Range
9.21016% of range14.50
52W High14.50 PLN
52W Low9.210 PLN
Profitability
Gross Margin43.76%
Oper. Margin3.87%
EBITDA Margin6.15%
Profit Margin0.17%
ROE0.22%
ROA0.14%
Growth
Revenue Growth-7.60%
Earnings Growth-44.10%
Cash Flow & Leverage
Operating CF854.50K $
CapEx (TTM)253.01K $
FCF Margin4.32%
FCF Yield6.11%
Net Debt3.98M $
Net Debt/EBITDA4.27
Balance Sheet
Debt/Equity0.30
Current Ratio1.39
Quick Ratio0.66
Book Value/Sh11.44 PLN
Cash/Share0.1010 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 16, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.19M
Float2.91M
Insiders34.41%
Institutions0.05%
Technical
SMA 509.743 (+3.5%)
SMA 20011.41 (-11.6%)
Beta0.31
S&P 52W Chg18.16%
Avg Vol (30d)2.57K
Avg Vol (10d)2.89K
Technical Indicators
RSI (14)62.5
MACD0.1192
MACD Signal0.0983
MACD Hist.+0.0210
BB Upper10.33 PLN
BB Middle10.06 PLN
BB Lower9.799 PLN
BB Width5.28%
ATR (14)0.1952 PLN
Vol Ratio (20d)0.57x